title: B-cell kinase lyn deficiency in patients with systemic lupus erythematosus.
abstract: BACKGROUND
  To better understand the molecular background of B-cell overactivity characterizing systemic lupus erythematosus (SLE), we examined the expression of the CD22 co-receptor and of kinase Lyn, which are involved in signaling inhibitory pathways, in B cells from patients with SLE.
  
  
  METHODS
  Two-color flow cytometry was used to study the expression of surface antigens on freshly isolated peripheral B cells from patients with SLE, disease-control patients, and healthy volunteers. Intracellular kinases Lyn and Syk were analyzed using Western immunoblots, and differences at the messenger RNA (mRNA) level were evaluated using semiquantitative polymerase chain reaction (PCR).
  
  
  RESULTS
  Expression of B-cell surface CD22 was intact in patients with SLE, but expression of the B-cell kinase Lyn was significantly decreased in resting, as well as in anti-sIgM-stimulated B-cell-enriched cell lysates obtained from 66% of patients with SLE. Lyn deficiency was disease-specific and unrelated to disease activity. Expression of B-cell kinase Syk was similar in all study groups. Semiquantitative PCR revealed that Lyn mRNA was significantly decreased in lupus patients with decreased Lyn protein expression, suggesting that Lyn deficiency may be caused at least in part by defects at the transcription level.
  
  
  CONCLUSIONS
  Decreased expression of Lyn in some patients with SLE represents a B-cell defect that may enhance our understanding of SLE molecular pathogenesis by providing rational therapeutic targets.
authors: First Department of Propedeutic Medicine, Athens University Medical School, Laikon Hospital, Greece. sliossis@hotmail.com
authors: S N
authors: SN
authors: Liossis
authors: E E
authors: EE
authors: Solomou
authors: M A
authors: MA
authors: Dimopoulos
authors: P
authors: P
authors: Panayiotidis
authors: M M
authors: MM
authors: Mavrikakis
authors: P P
authors: PP
authors: Sfikakis
mesh_terms: D000328:Adult; D015703:Antigens, CD / Q000032:analysis; D000944:Antigens, Differentiation, B-Lymphocyte / Q000032:analysis; D001323:Autoantibodies / Q000097:blood; D001402:B-Lymphocytes / Q000201:enzymology*; D015815:Cell Adhesion Molecules; D003165:Complement System Proteins / Q000032:analysis; D005260:Female; D006801:Humans; D037102:Lectins; D008180:Lupus Erythematosus, Systemic / Q000276:immunology*; D008213:Lymphocyte Activation; D008875:Middle Aged; D012333:RNA, Messenger / Q000032:analysis; D051918:Sialic Acid Binding Ig-like Lectin 2; D019061:src-Family Kinases / Q000172:deficiency* / Q000235:genetics
chemical_list: D015703:Antigens, CD; D000944:Antigens, Differentiation, B-Lymphocyte; D001323:Autoantibodies; C497867:CD22 protein, human; D015815:Cell Adhesion Molecules; D037102:Lectins; D012333:RNA, Messenger; D051918:Sialic Acid Binding Ig-like Lectin 2; D003165:Complement System Proteins; C060902:lyn protein-tyrosine kinase; D019061:src-Family Kinases